Cell

Daily rhythms in cancer-fighting T cells affect how well immunotherapy works

Updated

Abstract

Circadian rhythms significantly affect the quality and quantity of tumor-infiltrating lymphocytes, particularly CD8T cells.

  • Tumor-infiltrating lymphocytes display daily cycles influenced by the body's internal clock and the clock of endothelial cells in the tumor area.
  • Modifying the timing of treatments like chimeric antigen receptor T cell therapy and immune checkpoint blockade may enhance their effectiveness.
  • Circadian-dependent patterns in T cells from mouse models are linked to overall survival in melanoma patients.
  • Responses to anti-PD-1 therapy correlate with specific time-of-day T cell signatures.

Simplified

Full Text

Full text is available at the source.

Funding

Competing interests

Declaration of interests C.S. has been a consultant for Bayer and received speaker fees from Abbvie. M.J.P. has been a consultant for AstraZeneca, Debiopharm, Elstar Therapeutics, ImmuneOncia, KSQ Therapeutics, MaxiVax, Merck, Molecular Partners, Third Rock Ventures, and Tidal. F.S. received consulting fees from BMS/Celgene, Incyte, Kite/Gilead, speaker fees from Kite/Gilead, Incyte, travel support from Kite/Gilead, Novartis, AstraZeneca, Neovii, Janssen, and research funding from Kite/Gilead, Novartis, and BMS/Celgene. A.D.G. received consulting/advisory/lecture honoraria or research funding from Boehringer Ingelheim, SOTIO, Miltenyi Biotec, Novigenix, and IsoPlexis. R.B. received speaker fees from Janssen and is a mentee of the ENDEAVOUR-Breast program of Daichii Sankyo. All these relationships are unrelated to this study.
PubMed

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free